|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.56 USD | -0.22% |
|
-2.56% | -18.86% |
| 15/03 | Tranche Update on Champions Oncology, Inc.'s Equity Buyback Plan announced on April 5, 2023. | CI |
| 13/03 | Craig-Hallum Downgrades Champions Oncology to Hold From Buy | MT |
Champions Oncology, Inc. announced the appointment of Dr. Philip Breitfeld to its Board of Directors. Dr. Breitfeld has more than 30 years of experience in oncology. His appointment will further the company's efforts to accelerate growth and increase the adoption of its technology platform.
Philip Breitfeld, MD was most recently Global Vice President at Quintiles, responsible for the Therapeutic Centers of Excellence.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.86% | 62.12M | |
| +45.68% | 58.71B | |
| -3.27% | 41.31B | |
| +36.42% | 39.2B | |
| -10.22% | 27.4B | |
| +9.98% | 26.55B | |
| -22.02% | 18.98B | |
| +1.30% | 12.51B | |
| +26.49% | 12.08B | |
| +20.44% | 11.94B |
CHAMPIONS ONCOLOGY, INC. 
